|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1275 Pennsylvania Avenue, NW |
Address2 | Suite 700 |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Woonsocket |
State | RI |
Zip Code | 02895 |
Country | USA |
|
5. Senate ID# 302778-12
|
||||||||
|
6. House ID# 394420000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Shannon Penberthy |
Date | 10/20/2020 6:04:59 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing.
S. 1895, The Lower Health Care Costs Act of 2019
S. 2543, The Prescription Drug Pricing Reduction Act of 2019
H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Brooks |
|
|
|
Shannon |
Penberthy |
|
|
|
Amy |
Rosenbaum |
|
|
|
Sarah |
Schmidt |
|
|
|
Joy |
McGlaun |
|
|
|
Glen |
Chambers |
|
|
|
Melissa |
Schulman |
|
|
|
Kaitlyn |
Lane |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act.
H.R. 6776, The JOBS Credit Act of 2020
H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sarah |
Schmidt |
|
|
|
Elizabeth |
Brooks |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program.
Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020.
H.R. 3, The Lower Drug Costs Now Act of 2019
H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020
H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020
S. 1895, The Lower Health Care Costs Act of 2019
S.2543, The Prescription Drug Pricing Reduction Act of 2019
S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019
S. 3129, The Lower Costs, More Cures Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Brooks |
|
|
|
Amy |
Rosenbaum |
|
|
|
Sarah |
Schmidt |
|
|
|
Joy |
McGlaun |
|
|
|
Glen |
Chambers |
|
|
|
Kaitlyn |
Lane |
|
|
|
Shannon |
Penberthy |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to implementation and changes to the Affordable Care Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Brooks |
|
|
|
Sarah |
Schmidt |
|
|
|
Joy |
McGlaun |
|
|
|
Glen |
Chambers |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage.
H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019
H.R. 3630, The No Surprises Act of 2019
H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019
S. 1895, The Lower Health Care Costs Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Rosenbaum |
|
|
|
Elizabeth |
Brooks |
|
|
|
Sarah |
Schmidt |
|
|
|
Joy |
McGlaun |
|
|
|
Glen |
Chambers |
|
|
|
Shannon |
Penberthy |
|
|
|
Kaitlyn |
Lane |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Issues related to the competitive nature of the pharmacy benefit management industry.
S. 1895, The Lower Health Care Costs Act of 2019
S. 2543, The Prescription Drug Pricing Reduction Act of 2019
S. 4317, The Safe to Work Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Brooks |
|
|
|
Glen |
Chambers |
|
|
|
Amy |
Rosenbaum |
|
|
|
Sarah |
Schmidt |
|
|
|
Joy |
McGlaun |
|
|
|
Shannon |
Penberthy |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code POS
16. Specific lobbying issues
Issues related to the continuation and affordability of postal services.
H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
S. 2965, The USPS Fairness Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Penberthy |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Issues related to organized retail crime and product safety.
H.R. 7756/S. 3417, The Integrity, Notification and Fairness in Online Retail Marketplaces for Consumers Act of 2020
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Penberthy |
|
|
|
Elizabeth |
Brooks |
|
|
|
Sarah |
Schmidt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |